166 related articles for article (PubMed ID: 32333232)
21. Release of SR Proteins from CLK1 by SRPK1: A Symbiotic Kinase System for Phosphorylation Control of Pre-mRNA Splicing.
Aubol BE; Wu G; Keshwani MM; Movassat M; Fattet L; Hertel KJ; Fu XD; Adams JA
Mol Cell; 2016 Jul; 63(2):218-228. PubMed ID: 27397683
[TBL] [Abstract][Full Text] [Related]
22. M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.
Wang Y; Xiao H; Wang C; Wu H; He H; Yao C; Cui J; Li W
J Cell Biochem; 2020 Mar; 121(3):2330-2342. PubMed ID: 31692032
[TBL] [Abstract][Full Text] [Related]
23. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.
Zhang J; Wang G; Chu SJ; Zhu JS; Zhang R; Lu WW; Xia LQ; Lu YM; Da W; Sun Q
Oncotarget; 2016 Mar; 7(13):16180-93. PubMed ID: 26921249
[TBL] [Abstract][Full Text] [Related]
24. Manipulation of alternative splicing by a newly developed inhibitor of Clks.
Muraki M; Ohkawara B; Hosoya T; Onogi H; Koizumi J; Koizumi T; Sumi K; Yomoda J; Murray MV; Kimura H; Furuichi K; Shibuya H; Krainer AR; Suzuki M; Hagiwara M
J Biol Chem; 2004 Jun; 279(23):24246-54. PubMed ID: 15010457
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB.
Zhao H; Xu J; Wang Y; Jiang R; Li X; Zhang L; Che Y
Surg Oncol; 2018 Sep; 27(3):495-502. PubMed ID: 30217308
[TBL] [Abstract][Full Text] [Related]
27. Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention.
Uzor S; Zorzou P; Bowler E; Porazinski S; Wilson I; Ladomery M
Gene; 2018 Sep; 670():46-54. PubMed ID: 29802995
[TBL] [Abstract][Full Text] [Related]
28. New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.
Tazarki H; Zeinyeh W; Esvan YJ; Knapp S; Chatterjee D; Schröder M; Joerger AC; Khiari J; Josselin B; Baratte B; Bach S; Ruchaud S; Anizon F; Giraud F; Moreau P
Eur J Med Chem; 2019 Mar; 166():304-317. PubMed ID: 30731399
[TBL] [Abstract][Full Text] [Related]
29. CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer.
Uzor S; Porazinski SR; Li L; Clark B; Ajiro M; Iida K; Hagiwara M; Alqasem AA; Perks CM; Wilson ID; Oltean S; Ladomery MR
Sci Rep; 2021 Apr; 11(1):7963. PubMed ID: 33846420
[TBL] [Abstract][Full Text] [Related]
30. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.
Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587
[TBL] [Abstract][Full Text] [Related]
31. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.
Ge S; Zhang H; Deng T; Sun W; Ning T; Fan Q; Wang Y; Wang X; Zhang Q; Zhou Z; Yang H; Ying G; Ba Y
Invest New Drugs; 2019 Oct; 37(5):923-934. PubMed ID: 30607520
[TBL] [Abstract][Full Text] [Related]
32. Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment.
Zu M; Li C; Fang JS; Lian WW; Liu AL; Zheng LS; Du GH
Molecules; 2015 Nov; 20(11):19735-47. PubMed ID: 26540031
[TBL] [Abstract][Full Text] [Related]
33. Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
Kong F; Sun T; Kong X; Xie D; Li Z; Xie K
Clin Cancer Res; 2018 May; 24(10):2440-2451. PubMed ID: 29367428
[No Abstract] [Full Text] [Related]
34. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
36. A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Puttamallesh VN; Jain AP; Pinto SM; Balaji SA; Chavan S; Sahasrabuddhe NA; Mathur PP; Kumar MM; Prasad TS; Santosh V; Sukumar G; Califano JA; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
Sci Rep; 2016 Oct; 6():36132. PubMed ID: 27796319
[TBL] [Abstract][Full Text] [Related]
37. Nuclear protein kinase CLK1 uses a non-traditional docking mechanism to select physiological substrates.
Keshwani MM; Hailey KL; Aubol BE; Fattet L; McGlone ML; Jennings PA; Adams JA
Biochem J; 2015 Dec; 472(3):329-38. PubMed ID: 26443864
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
Cao Y; Wang J; Tian H; Fu GH
J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.
Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G
Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]